-
1
-
-
0023008693
-
Proglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing
-
Mojsov S, Heinrich G, Wilson IB, Ravazzola M, Orci L, Habener JF. 1986 Proglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing. J Biol Chem. 261:11880-11889.
-
(1986)
J Biol Chem
, vol.261
, pp. 11880-11889
-
-
Mojsov, S.1
Heinrich, G.2
Wilson, I.B.3
Ravazzola, M.4
Orci, L.5
Habener, J.F.6
-
2
-
-
0023638829
-
Glucagon-like peptide-1 7-36: A physiological incretin in man
-
Kreymann B, Williams G, Ghatei MA, Bloom SR. 1987 Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet. 2:1300-1303.
-
(1987)
Lancet
, vol.2
, pp. 1300-1303
-
-
Kreymann, B.1
Williams, G.2
Ghatei, M.A.3
Bloom, S.R.4
-
3
-
-
0026659679
-
Glucagon-like peptide-1, a new hormone of the entero-insular axis
-
Ørskov C. 1992 Glucagon-like peptide-1, a new hormone of the entero-insular axis. Diabetologia. 35:701-711.
-
(1992)
Diabetologia
, vol.35
, pp. 701-711
-
-
Ørskov, C.1
-
4
-
-
0029043139
-
Cell and molecular biology of the incretin hormones glucagon-like peptide-I and glucose-dependent insulin releasing polypeptide
-
Fehmann HC, Göke R, Göke B. 1995 Cell and molecular biology of the incretin hormones glucagon-like peptide-I and glucose-dependent insulin releasing polypeptide. Endocr Rev. 16:390-410.
-
(1995)
Endocr Rev
, vol.16
, pp. 390-410
-
-
Fehmann, H.C.1
Göke, R.2
Göke, B.3
-
5
-
-
0023104829
-
Truncated glucagon-like peptide I, an insulin-releasing hormone from the distal gut
-
Holst JJ, Ørskov C, Schwartz TW, Nielsen OV. 1987 Truncated glucagon-like peptide I, an insulin-releasing hormone from the distal gut. FEBS Lett. 211:169-174.
-
(1987)
FEBS Lett
, vol.211
, pp. 169-174
-
-
Holst, J.J.1
Ørskov, C.2
Schwartz, T.W.3
Nielsen, O.V.4
-
6
-
-
0026080393
-
(7-36)amide: Influences on basal and stimulated insulin and glucagon secretion in the mouse
-
(7-36)amide: influences on basal and stimulated insulin and glucagon secretion in the mouse. Pancreas. 6:208-215.
-
(1991)
Pancreas
, vol.6
, pp. 208-215
-
-
Fridolf, T.1
Böttcher, G.2
Sundler, F.3
Ahrén, B.4
-
7
-
-
0026596851
-
Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus
-
Gutniak MK, Ørskov C, Holst JJ, Ahrén B, Efendic S. 1992 Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus. N Engl J Med. 326:1316-1322.
-
(1992)
N Engl J Med
, vol.326
, pp. 1316-1322
-
-
Gutniak, M.K.1
Ørskov, C.2
Holst, J.J.3
Ahrén, B.4
Efendic, S.5
-
8
-
-
0026542396
-
Insulinotropic action of glucagon-like peptide-1-(7-37) in diabetic and nondiabetic subjects
-
Nathan DM, Schreiber E, Mojsov S, Habener JF. 1992 Insulinotropic action of glucagon-like peptide-1-(7-37) in diabetic and nondiabetic subjects. Diabetes Care. 15:270-276.
-
(1992)
Diabetes Care
, vol.15
, pp. 270-276
-
-
Nathan, D.M.1
Schreiber, E.2
Mojsov, S.3
Habener, J.F.4
-
9
-
-
0028296643
-
Glucagon-like peptide 1 enhances glucose tolerance both by stimulation of insulin release and by increasing insulin-independent glucose disposal
-
D'Alessio DA, Kahn SE, Leusner CR, Ensinck JW. 1994 Glucagon-like peptide 1 enhances glucose tolerance both by stimulation of insulin release and by increasing insulin-independent glucose disposal. J Clin Invest. 93:2263-2266.
-
(1994)
J Clin Invest
, vol.93
, pp. 2263-2266
-
-
D'Alessio, D.A.1
Kahn, S.E.2
Leusner, C.R.3
Ensinck, J.W.4
-
10
-
-
0028224617
-
The insulinotropic actions of glucose-dependent insulinotyropic polypeptide (GIP) and glucagon-like peptide-1 (7-37) in normal and diabetic subjects
-
Elahi D, McAloon-Dyke M, Fukagawa NK, et al. 1994 The insulinotropic actions of glucose-dependent insulinotyropic polypeptide (GIP) and glucagon-like peptide-1 (7-37) in normal and diabetic subjects. Regul Pept. 51:63-74.
-
(1994)
Regul Pept
, vol.51
, pp. 63-74
-
-
Elahi, D.1
McAloon-Dyke, M.2
Fukagawa, N.K.3
-
11
-
-
0028930130
-
Insulinotropic action of truncated glucagon-like peptide-1 in mice
-
Ahrén B. 1995 Insulinotropic action of truncated glucagon-like peptide-1 in mice. Acta Physiol Scand. 153:205-206.
-
(1995)
Acta Physiol Scand
, vol.153
, pp. 205-206
-
-
Ahrén, B.1
-
12
-
-
0028904931
-
Insulinotropic actions of intravenous glucagon-like peptide-1 (7-36) [7-36 amide] in the fasting state in healthy subjects
-
Qualmann C, Nauck MA, Holst JJ, Ørskov C, Creutzfeldt W. 1995 Insulinotropic actions of intravenous glucagon-like peptide-1 (7-36) [7-36 amide] in the fasting state in healthy subjects. Acta Diabetol. 32:13-16.
-
(1995)
Acta Diabetol
, vol.32
, pp. 13-16
-
-
Qualmann, C.1
Nauck, M.A.2
Holst, J.J.3
Ørskov, C.4
Creutzfeldt, W.5
-
13
-
-
0029552470
-
Glucose-dependent action of glucagon-like peptide-1 (7-37) in vivo during short or long-term administration
-
Hargrove DM, Nardone NA, Persson LM, Parker JC, Stevenson RW. 1995 Glucose-dependent action of glucagon-like peptide-1 (7-37) in vivo during short or long-term administration. Metabolism. 44:1231-1237.
-
(1995)
Metabolism
, vol.44
, pp. 1231-1237
-
-
Hargrove, D.M.1
Nardone, N.A.2
Persson, L.M.3
Parker, J.C.4
Stevenson, R.W.5
-
14
-
-
0028071448
-
Subcutaneous injection of the incretin hormone glucagon-like peptide 1 abolishes postprandial glycemia in NIDDM
-
Gutniak MK, Linde B, Holst JJ, Efendic S. 1994 Subcutaneous injection of the incretin hormone glucagon-like peptide 1 abolishes postprandial glycemia in NIDDM. Diabetes Care. 17:1039-1044.
-
(1994)
Diabetes Care
, vol.17
, pp. 1039-1044
-
-
Gutniak, M.K.1
Linde, B.2
Holst, J.J.3
Efendic, S.4
-
15
-
-
0027248866
-
Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients
-
Nauck MA, Kleine N, Ørskov C, Holst JJ, Willms B, Creutzfeldt W. 1993 Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients. Diabetologia. 36:741-744.
-
(1993)
Diabetologia
, vol.36
, pp. 741-744
-
-
Nauck, M.A.1
Kleine, N.2
Ørskov, C.3
Holst, J.J.4
Willms, B.5
Creutzfeldt, W.6
-
16
-
-
0030068620
-
Gastric emptying, glucose responses, and insulin secretion after a liquid test meal: Effects of exogenous glucagon-like peptide-1 (GLP-1)-(7-36) amide in type 2 (noninsulin-dependent) diabetic patients
-
Willms B, Werner J, Holst JJ, Ørskov C, Creutzfeldt W, Nauck MA. 1996 Gastric emptying, glucose responses, and insulin secretion after a liquid test meal: effects of exogenous glucagon-like peptide-1 (GLP-1)-(7-36) amide in type 2 (noninsulin-dependent) diabetic patients. J Clin Endocrinol Metab. 81:327-332.
-
(1996)
J Clin Endocrinol Metab
, vol.81
, pp. 327-332
-
-
Willms, B.1
Werner, J.2
Holst, J.J.3
Ørskov, C.4
Creutzfeldt, W.5
Nauck, M.A.6
-
17
-
-
0026110135
-
B cells in type 2 diabetes mellitus
-
Porte, Jr, D. 1991 B cells in type 2 diabetes mellitus. Diabetes. 40:166-180.
-
(1991)
Diabetes
, vol.40
, pp. 166-180
-
-
Porte Jr., D.1
-
19
-
-
0026793446
-
Role of glucose and insulin resistance in development of type 2 diabetes mellitus: Results of a 25-year follow-up study
-
Martín BC, Warram JH, Krolewski AS, Bergman RN, Soeldner JS, Kahn CR. 1992 Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet. 2:925-929.
-
(1992)
Lancet
, vol.2
, pp. 925-929
-
-
Martín, B.C.1
Warram, J.H.2
Krolewski, A.S.3
Bergman, R.N.4
Soeldner, J.S.5
Kahn, C.R.6
-
20
-
-
0023924773
-
Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians
-
Lillioja S, Mott DM, Howard BV, et al. 1988 Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. N Engl J Med. 318:1217-1225.
-
(1988)
N Engl J Med
, vol.318
, pp. 1217-1225
-
-
Lillioja, S.1
Mott, D.M.2
Howard, B.V.3
-
21
-
-
0022450553
-
Beta-cell dysfunction, rather than insulin insensitivity, is the primary defect in familial type 2 diabetes
-
O'Rahilly SP, Rudenski AS, Burnett MA, Nugent Z, Hosker JP, Darling P. 1986 Beta-cell dysfunction, rather than insulin insensitivity, is the primary defect in familial type 2 diabetes. Lancet. 2:360-364.
-
(1986)
Lancet
, vol.2
, pp. 360-364
-
-
O'Rahilly, S.P.1
Rudenski, A.S.2
Burnett, M.A.3
Nugent, Z.4
Hosker, J.P.5
Darling, P.6
-
22
-
-
0021815093
-
Abnormal glucose modulation of islet A- and B-cell responses to arginine in non-insulin-dependent diabetes mellitus
-
Dimitriadis GD, Pekling GB, Gerich JE. 1985 Abnormal glucose modulation of islet A- and B-cell responses to arginine in non-insulin-dependent diabetes mellitus. Diabetes. 34:541-547.
-
(1985)
Diabetes
, vol.34
, pp. 541-547
-
-
Dimitriadis, G.D.1
Pekling, G.B.2
Gerich, J.E.3
-
23
-
-
0028880997
-
Role of insulin resistance in the pathogenesis of NIDDM
-
Yki-Järvinen H. 1995 Role of insulin resistance in the pathogenesis of NIDDM. Diabetologia. 38:1378-1388.
-
(1995)
Diabetologia
, vol.38
, pp. 1378-1388
-
-
Yki-Järvinen, H.1
-
24
-
-
0023589251
-
Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type II diabetics
-
Baron AD, Shaeffer L, Shragg P, Kolterman OG. 1987 Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type II diabetics. Diabetes. 36:274-283.
-
(1987)
Diabetes
, vol.36
, pp. 274-283
-
-
Baron, A.D.1
Shaeffer, L.2
Shragg, P.3
Kolterman, O.G.4
-
25
-
-
0021751981
-
Diminished B cell secretory capacity in patients with non-insulin-dependent diabetes mellitus
-
Ward WK, Bolgiano DC, McKnight B, Halter JB, Porte, Jr, D. 1984 Diminished B cell secretory capacity in patients with non-insulin-dependent diabetes mellitus. J Clin Invest. 74:1318-1328.
-
(1984)
J Clin Invest
, vol.74
, pp. 1318-1328
-
-
Ward, W.K.1
Bolgiano, D.C.2
McKnight, B.3
Halter, J.B.4
Porte Jr., D.5
-
26
-
-
0018520840
-
Glucose clamp technique: A method for quantifying insulin secretion and resistance
-
DeFronzo RA, Tobin JD, Andres R. 1979 Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am. J Physiol. 237:E214-E223.
-
(1979)
Am. J Physiol.
, vol.237
-
-
DeFronzo, R.A.1
Tobin, J.D.2
Andres, R.3
-
27
-
-
0016767914
-
Potentiation of insulin release by glucose in man
-
Cerasi E. 1975 Potentiation of insulin release by glucose in man. Acta Endocrinol. 79:511-534.
-
(1975)
Acta Endocrinol
, vol.79
, pp. 511-534
-
-
Cerasi, E.1
-
28
-
-
0019351275
-
Time and dose dependencies for priming effect of glucose on insulin secretion
-
Grill V. 1981 Time and dose dependencies for priming effect of glucose on insulin secretion. Am J Physiol. 240:E24-E31.
-
(1981)
Am J Physiol
, vol.240
-
-
Grill, V.1
-
29
-
-
0028281773
-
Production and secretion of amidated and glycine-extended glucagon-like peptide-1 (GLP-1) in man
-
Ørskov C, Rabenhøj L, Kofod H, Wettergren A, Holst JJ. 1994 Production and secretion of amidated and glycine-extended glucagon-like peptide-1 (GLP-1) in man. Diabetes. 43:535-539.
-
(1994)
Diabetes
, vol.43
, pp. 535-539
-
-
Ørskov, C.1
Rabenhøj, L.2
Kofod, H.3
Wettergren, A.4
Holst, J.J.5
-
31
-
-
0029060435
-
Drugs on the horizon for treatment of type 2 diabetes
-
Rachman J, Turner RC. 1995 Drugs on the horizon for treatment of type 2 diabetes. Diabet Med. 12:467-478.
-
(1995)
Diabet Med
, vol.12
, pp. 467-478
-
-
Rachman, J.1
Turner, R.C.2
-
32
-
-
0027772917
-
The incretin notion and its relevance to diabetes
-
Habener JF. 1993 The incretin notion and its relevance to diabetes. Endocrinol Metab Clin North Am. 22:775-794.
-
(1993)
Endocrinol Metab Clin North Am
, vol.22
, pp. 775-794
-
-
Habener, J.F.1
-
33
-
-
0029020729
-
Glucose modulation of insulin and glucagon secretion is altered in impaired glucose tolerance
-
Larsson H, Berglund G, Ahrén B. 1995 Glucose modulation of insulin and glucagon secretion is altered in impaired glucose tolerance. J Clin Endocrinol Metab. 80:1778-1782.
-
(1995)
J Clin Endocrinol Metab
, vol.80
, pp. 1778-1782
-
-
Larsson, H.1
Berglund, G.2
Ahrén, B.3
-
34
-
-
0028156856
-
Effect of glucagon-like peptide-1 (proglucagon 78-107amide) on hepatic glucose production in healthy man
-
Hvidberg A, Toft Nielsen M, Hilsted J, Ørskov C, Holst JJ. 1994 Effect of glucagon-like peptide-1 (proglucagon 78-107amide) on hepatic glucose production in healthy man. Metabolism. 43:104-108.
-
(1994)
Metabolism
, vol.43
, pp. 104-108
-
-
Hvidberg, A.1
Toft Nielsen, M.2
Hilsted, J.3
Ørskov, C.4
Holst, J.J.5
-
35
-
-
0019995650
-
Hepatic and peripheral insulin resistance: A common feature of type 2 (non-insulin-dependent) and type 1 (insulin-dependent) diabetes mellitus
-
DeFronzo RA, Simonson D, Ferrannini E. 1982 Hepatic and peripheral insulin resistance: a common feature of type 2 (non-insulin-dependent) and type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 23:313-319.
-
(1982)
Diabetologia
, vol.23
, pp. 313-319
-
-
DeFronzo, R.A.1
Simonson, D.2
Ferrannini, E.3
-
36
-
-
0016582510
-
Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood
-
Horwitz DL, Starr JI, Mako ME, et al. 1975 Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood. J Clin Invest. 55:1278-1283.
-
(1975)
J Clin Invest
, vol.55
, pp. 1278-1283
-
-
Horwitz, D.L.1
Starr, J.I.2
Mako, M.E.3
-
37
-
-
0023239175
-
Insulin suppresses its own secretion in vivo
-
Argoud GM, Schade DS, Eaton RP. 1987 Insulin suppresses its own secretion in vivo. Diabetes. 36:959-962.
-
(1987)
Diabetes
, vol.36
, pp. 959-962
-
-
Argoud, G.M.1
Schade, D.S.2
Eaton, R.P.3
|